3-D ultrasound upgrade enters market
Biomedicom, a 1998 spin-off from Silicon Graphics, has begun shipping a 3-D ultrasound imaging platform called SonoReal. The product is compatible with existing 2-D ultrasound systems and features a positional sensor, which attaches to a 2-D transducer
Biomedicom, a 1998 spin-off from Silicon Graphics, has begun shipping a 3-D ultrasound imaging platform called SonoReal. The product is compatible with existing 2-D ultrasound systems and features a positional sensor, which attaches to a 2-D transducer using a simple clip-on device, enabling the physician or sonographer to acquire slices that can be reconstructed into 3-D volume. Proprietary software supports semiautomated image segmentation capability. By drawing a contour around a selected area, the SonoReal can define and surround a region or organ of interest, automatically removing obscuring tissues. The product debuted earlier this year at the annual meetings of the American College of Obstetricians and Gynecologists and the American Institute of Ultrasound in Medicine.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
What if Radiology Turns Out Exactly the Way We Predict it Will?
May 19th 2025Whether it is reimbursement cuts or continued attempts to push non-radiologist image interpretation, where do we draw the line between inspired protest and misspent energy criticizing things that are doomed to fail or things we have no control over?
What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence
May 16th 2025For patients at high-risk for biochemical recurrence of prostate cancer, PSMA PET/CT findings revealed that 77 percent had one or more prostate lesions after undergoing local radiation therapy or radical prostatectomy, according to a recent study.
